Search
for
Sort by
Research 31–60 of 345
- Drug eruptions in dermatology
- Fixed-Drug Eruption due to Dextromethorphan
- Generalized maculopapular rash and fever
- Cutaneous Reactions to Drugs
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Skin disorders associated with the COVID‐19 pandemic: A review
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Cutaneous drug reactions
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Drug-Induced Skin, Nail and Hair Disorders
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Non‐infective mucocutaneous presentations of human immunodeficiency virus infection
- Cutaneous manifestations of COVID-19
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Abstract- Poster
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Management of Dermatologic Toxicities
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome